制药

China liver problems boost demand for US blood plasma

An unlikely transpacific trade in human blood plasma products is flourishing between the US and China, where a spate of liver diseases has driven up demand for a protein contained within the vital fluid.

Chinese patients last year consumed about 300 tonnes of serum albumin — the main protein component in human plasma — roughly half of the global total, according to analysts. About 60 per cent of that was imported, and demand is growing at 15 per cent annually.

Naturally produced by the liver, the protein can be harvested by “fractionation” of donated plasma, the liquid part of human blood. Donors in the US are typically paid a fee.

您已阅读18%(637字),剩余82%(2902字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×